These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9595865)

  • 1. Practicability and acceptance of subcutaneous self-administration of the selective serotonin agonist sumatriptan.
    Göbel H; Baar H; Beiküfner HD; Böhme K; Beckmann-Reinhold A
    Headache; 1998 Apr; 38(4):267-9. PubMed ID: 9595865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study.
    Schoenen J; Bulcke J; Caekebeke J; Dehaene I; De Keyser J; Hildebrand G; Joffroy A; Laloux P; Louis P; Monseu G
    Cephalalgia; 1994 Feb; 14(1):55-63. PubMed ID: 8200027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
    Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
    Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector.
    Gross ML; Kay J; Turner AM; Jewsbury J; Cleal AL
    Headache; 1995; 35(10):601-6. PubMed ID: 8550361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan. An updated review of its use in migraine.
    Perry CM; Markham A
    Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
    Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
    Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of operationalized computer diagnosis on the therapeutic results of sumatriptan in general practice.
    Göbel H; Heinze A; Kuhn K; Heuss D; Lindner V
    Cephalalgia; 1998 Sep; 18(7):481-6. PubMed ID: 9793701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations.
    Weidmann E; Unger J; Blair S; Friesen C; Hart C; Cady R
    Clin Ther; 2003 Jan; 25(1):235-46. PubMed ID: 12637123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sumatriptan-nonresponders: a survey in 366 migraine patients.
    Visser WH; de Vriend RH; Jaspers NH; Ferrari MD
    Headache; 1996 Sep; 36(8):471-5. PubMed ID: 8824001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan: pharmacological basis and clinical results.
    Dahlöf CG
    Curr Med Res Opin; 2001; 17 Suppl 1():s35-45. PubMed ID: 12463276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
    Géraud G; Valette C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine.
    Tfelt-Hansen P; Henry P; Mulder LJ; Scheldewaert RG; Schoenen J; Chazot G
    Lancet; 1995 Oct; 346(8980):923-6. PubMed ID: 7564725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial.
    Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO
    Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
    Jensen K; Tfelt-Hansen P; Hansen EW; Krøis EH; Pedersen OS
    Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
    Winner P; Ricalde O; Le Force B; Saper J; Margul B
    Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chest symptoms after sumatriptan: a two-year clinical practice review in 735 consecutive migraine patients.
    Visser WH; Jaspers NM; de Vriend RH; Ferrari MD
    Cephalalgia; 1996 Dec; 16(8):554-9. PubMed ID: 8980858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.
    Plosker GL; McTavish D
    Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat.
    Tfelt-Hansen P
    Cephalalgia; 1998 Oct; 18(8):532-8. PubMed ID: 9827244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.